Sign in
4

Changes in Ownership

Krystal Biotech, Inc. Filed Acc 0001860010-22-000002

Options or other derivatives

  • Chief Commercial Officer acquired 50,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
ORTH ANDREW C. Chief Commercial Officer 2022-02-28 Grant or award · Stock Option (Right to Buy) +50,000 50,000 D
Loading xslF345X03/wf-form4_164618775853736.xml…